Pricing
Login
Home
Charts
Search
Watchlist
Products

Innova Captab Ltd

INNOVACAP
₹977.80-2.74%20 Nov 2026
Reports
Pharma CRAMS

Innova Captab Ltd

INNOVACAP
₹977.80
-2.74%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹5,595Cr
Close
Close Price
₹977.80
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
33.56
PS
Price To Sales
3.00
Revenue
Revenue
₹1,865Cr
Rev Gr TTM
Revenue Growth TTM
36.84%
PAT Gr TTM
PAT Growth TTM
34.00%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
302263294318316315352380450448471496
Growth YoY
Revenue Growth YoY%
25.09.026.212.54.619.819.519.542.342.333.930.5
Expenses
ExpensesCr
258225252268270267299329381383398426
Operating Profit
Operating ProfitCr
453842504748525269657370
OPM
OPM%
14.714.514.315.614.715.214.813.615.414.515.514.1
Other Income
Other IncomeCr
262243442222
Interest Expense
Interest ExpenseCr
710002364544
Depreciation
DepreciationCr
5355510111111111212
PBT
PBTCr
354039474639433956515956
Tax
TaxCr
101110121110121014131514
PAT
PATCr
252929353430313042384442
Growth YoY
PAT Growth YoY%
28.466.567.652.836.13.05.2-15.223.328.842.343.0
NPM
NPM%
8.310.910.011.010.89.48.87.89.48.59.48.6
EPS
EPS₹
4.45.05.26.16.05.25.45.27.46.77.77.4
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
302263294318316315352380450448471496
Growth YoY
Revenue Growth YoY%
25.09.026.212.54.619.819.519.542.342.333.930.5
Expenses
ExpensesCr
258225252268270267299329381383398426
Operating Profit
Operating ProfitCr
453842504748525269657370
OPM
OPM%
14.714.514.315.614.715.214.813.615.414.515.514.1
Other Income
Other IncomeCr
262243442222
Interest Expense
Interest ExpenseCr
710002364544
Depreciation
DepreciationCr
5355510111111111212
PBT
PBTCr
354039474639433956515956
Tax
TaxCr
101110121110121014131514
PAT
PATCr
252929353430313042384442
Growth YoY
PAT Growth YoY%
28.466.567.652.836.13.05.2-15.223.328.842.343.0
NPM
NPM%
8.310.910.011.010.89.48.87.89.48.59.48.6
EPS
EPS₹
4.45.05.26.16.05.25.45.27.46.77.77.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3563734118019261,0811,2441,6301,865
Growth
Revenue Growth%
4.910.094.915.716.715.031.136.8
Expenses
ExpensesCr
3153223567058139271,0581,3871,588
Operating Profit
Operating ProfitCr
41515496114154186243278
OPM
OPM%
11.513.613.312.012.314.315.014.914.9
Other Income
Other IncomeCr
01139121278
Interest Expense
Interest ExpenseCr
6546202121717
Depreciation
DepreciationCr
1110681116254546
PBT
PBTCr
2538468692130171188222
Tax
TaxCr
51012222435434755
PAT
PATCr
202835646894128141167
Growth
PAT Growth%
40.323.785.46.338.836.09.934.0
NPM
NPM%
5.67.58.48.07.38.710.38.78.9
EPS
EPS₹
4.15.87.213.314.218.722.424.629.1
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3563734118019261,0811,2441,6301,865
Growth
Revenue Growth%
4.910.094.915.716.715.031.136.8
Expenses
ExpensesCr
3153223567058139271,0581,3871,588
Operating Profit
Operating ProfitCr
41515496114154186243278
OPM
OPM%
11.513.613.312.012.314.315.014.914.9
Other Income
Other IncomeCr
01139121278
Interest Expense
Interest ExpenseCr
6546202121717
Depreciation
DepreciationCr
1110681116254546
PBT
PBTCr
2538468692130171188222
Tax
TaxCr
51012222435434755
PAT
PATCr
202835646894128141167
Growth
PAT Growth%
40.323.785.46.338.836.09.934.0
NPM
NPM%
5.67.58.48.07.38.710.38.78.9
EPS
EPS₹
4.15.87.213.314.218.722.424.629.1
Sales CAGR
1 Year31%
3 Years21%
5 Years32%
TTM37%
EBITDA CAGR
1 Year30%
3 Years29%
5 Years35%
TTM40%
PAT CAGR
1 Year10%
3 Years28%
5 Years33%
TTM34%
Avg. ROCE
1 Year14%
3 Years14%
5 Years17%
TTM16%
CFO / EBITDA
1 Year48%
3 Years56%
5 Years57%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
121212124857575757
Reserves
ReservesCr
70981331972297749021,0341,110
Current Liabilities
Current LiabilitiesCr
112120215295278265353495573
Non Current Liabilities
Non Current LiabilitiesCr
28141072150225268252253
Total Liabilities
Total LiabilitiesCr
2232453705757041,3211,5801,8371,994
Current Assets
Current AssetsCr
1431712703794425806969231,109
Non Current Assets
Non Current AssetsCr
807499196262741885914885
Total Assets
Total AssetsCr
2232453705757041,3211,5801,8371,994
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
121212124857575757
Reserves
ReservesCr
70981331972297749021,0341,110
Current Liabilities
Current LiabilitiesCr
112120215295278265353495573
Non Current Liabilities
Non Current LiabilitiesCr
28141072150225268252253
Total Liabilities
Total LiabilitiesCr
2232453705757041,3211,5801,8371,994
Current Assets
Current AssetsCr
1431712703794425806969231,109
Non Current Assets
Non Current AssetsCr
807499196262741885914885
Total Assets
Total AssetsCr
2232453705757041,3211,5801,8371,994

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
193142596714664117
Investing Cash Flow
Investing Cash FlowCr
-9-6-20-188-91-499-152-107
Financing Cash Flow
Financing Cash FlowCr
-9-23-191252736192-22
Net Cash Flow
Net Cash FlowCr
113-5384-12
Free Cash Flow
Free Cash FlowCr
112723-21-11-141-10856
CFO To PAT
CFO To PAT%
95.0110.4120.592.198.8155.149.882.7
CFO To EBITDA
CFO To EBITDA%
46.360.576.361.359.194.834.348.0
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
193142596714664117
Investing Cash Flow
Investing Cash FlowCr
-9-6-20-188-91-499-152-107
Financing Cash Flow
Financing Cash FlowCr
-9-23-191252736192-22
Net Cash Flow
Net Cash FlowCr
113-5384-12
Free Cash Flow
Free Cash FlowCr
112723-21-11-141-10856
CFO To PAT
CFO To PAT%
95.0110.4120.592.198.8155.149.882.7
CFO To EBITDA
CFO To EBITDA%
46.360.576.361.359.194.834.348.0

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,5655,0213,9345,595
Price To Earnings
Price To Earnings
27.239.227.933.6
Price To Sales
Price To Sales
2.44.02.43.0
Price To Book
Price To Book
3.15.23.64.8
EV To EBITDA
EV To EBITDA
17.628.417.621.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.821.421.519.521.827.428.928.428.4
OPM
OPM%
11.513.613.312.012.314.315.014.914.9
NPM
NPM%
5.67.58.48.07.38.710.38.78.9
ROCE
ROCE%
19.625.626.422.421.814.013.414.315.7
ROE
ROE%
24.125.323.830.724.611.313.412.914.3
ROA
ROA%
8.911.49.311.19.77.18.17.78.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,5655,0213,9345,595
Price To Earnings
Price To Earnings
27.239.227.933.6
Price To Sales
Price To Sales
2.44.02.43.0
Price To Book
Price To Book
3.15.23.64.8
EV To EBITDA
EV To EBITDA
17.628.417.621.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.821.421.519.521.827.428.928.428.4
OPM
OPM%
11.513.613.312.012.314.315.014.914.9
NPM
NPM%
5.67.58.48.07.38.710.38.78.9
ROCE
ROCE%
19.625.626.422.421.814.013.414.315.7
ROE
ROE%
24.125.323.830.724.611.313.412.914.3
ROA
ROA%
8.911.49.311.19.77.18.17.78.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr18,45518,2349,7975,5952,7221,9841,812
Close PriceClose₹1,609.30451.70517.60977.80220.76961.25115.57
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE97.5632.3533.5630.41
Price To SalesPS10.965.188.943.001.472.190.66
RevenueRevenueCr1,6843,5221,0961,8651,8519042,756
Revenue Growth TTMRev Gr TTM%10.7%-6.0%-7.0%36.8%8.9%19.0%-0.1%
PAT Growth TTMPAT Gr TTM%-104.1%-60.3%-19.0%34.0%-149.5%8.9%-184.9%
Market CapitalizationMkt CapCr18,45518,2349,7975,5952,7221,9841,812
Close PriceClose₹1,609.30451.70517.60977.80220.76961.25115.57
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE97.5632.3533.5630.41
Price To SalesPS10.965.188.943.001.472.190.66
RevenueRevenueCr1,6843,5221,0961,8651,8519042,756
Revenue Growth TTMRev Gr TTM%10.7%-6.0%-7.0%36.8%8.9%19.0%-0.1%
PAT Growth TTMPAT Gr TTM%-104.1%-60.3%-19.0%34.0%-149.5%8.9%-184.9%